Omission of sentinel lymph node biopsy in patients with clinically axillary lymph node-negative early breast cancer (OMSLNB): protocol for a prospective, non-inferiority, single-arm, phase II clinical trial in China

Authors

Le‐Xin Wang (ORCID: https://orcid.org/0000-0002-9760-7436)
Jingjing Ding (ORCID: https://orcid.org/0000-0002-9700-4504)
Xiaoming Zha (ORCID: https://orcid.org/0000-0003-2604-811X)
Jue Wang (ORCID: https://orcid.org/0000-0002-7134-3401)
X. Li (ORCID: https://orcid.org/0000-0002-3167-8629)
Yuanyuan Wang (ORCID: https://orcid.org/0000-0001-9472-8606)
Hao Yao (ORCID: https://orcid.org/0000-0002-5246-5550)
Ran Zheng (ORCID: https://orcid.org/0000-0001-7786-5094)
Lingjun Ma (ORCID: https://orcid.org/0000-0003-2223-7626)
Yichun Gong

Institutions

Nanjing Medical University (CN)

Publication Details

Journal: BMJ Open
Published: 2024-09-01
DOI: https://doi.org/10.1136/bmjopen-2024-087700
Citations: 6
Primary Topic: Breast Cancer Treatment Studies
Type: article
Field-Weighted Citation Impact: 1.71

Funders

Government of Jiangsu Province

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Omission of sentinel lymph node biopsy in patients with clinically axillary lymph node-negative early breast cancer (OMSLNB): protocol for a prospective, non-inferiority, single-arm, phase II clinical trial in China

Le‐Xin Wang, Jingjing Ding, Xiaoming Zha, Jue Wang et al.

Sep 1, 2024

6 citations

BMJ Open

Breast Cancer Treatment Studies

1.71

article

Omission of sentinel lymph node biopsy in patients with clinically axillary lymph node-negative early breast cancer (OMSLNB): protocol for a prospective, non-inferiority, single-arm, phase II clinical trial in China

Le‐Xin Wang, Jingjing Ding, Xiaoming Zha, Jue Wang, X. Li, Yuanyuan Wang, Hao Yao, Ran Zheng, Lingjun Ma, Yichun Gong

September 1, 2024article en

6 citations

Abstract

No abstract available for this paper.

BMJ OpenVol. 14(9)

Nanjing Medical University (CN)

Government of Jiangsu Province

Good health and well-being

Openalex Percentile: Top 15%

Breast Cancer Treatment Studies

1.71

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.